PROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number PL-31790-02. Manufactured by: Flowonix Medical Inc., --- The correction involves the labeling of the device plus the following Prometra II pump labeling is also being revised: Intrathecal Catheter IFU, REF 11823, PL-22790-02; Catheter Revision Kit IFU, REF 11 830, PL-21798-02; Refill Kit IFU, REF 11825, PL-21794-00; Prometra II Patient Implant Card (Permanent) PL-32300-01; Prometra II Patient Implant Card (Temporary): PL-32375-01; Prometra II Patient Guide: PL-31912-01. The Prometra Programmable Infusion Pump System is indicated for intrathecal infusion of Infumorph (preservative-free morphine sulfate sterile solution) or preservative-free sterile 0.9% saline solution (sodium chloride injection, USP).
Published July 26, 2017 · Recall initiated: May 22, 2017
Summary
FDA records medical device Class II recall Z-2740-2017, published July 26, 2017 and initiated May 22, 2017. Recalling firm: Flowonix Medical, Inc.; Status: Terminated; Reported quantity: US: 2204 units; Lot: All. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Flowonix Medical received a report of a patient implanted with the Prometra II Programmable Pump who may have received a fatal drug overdose during an MRI procedure. The Prometra II pump has an FDA-approved design feature intended to permit safe exposure to an MRI without removing drug from the reservoir.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Flowonix Medical, Inc.
- Distributor
- Nationwide Distribution
- Lot
- All
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAgfa Healthcare NX 3.0.8950 Imaging Processing SoftwareJuly 26, 2017
- FDAMAKO RIO Standard System, internal cPCI Card CageP/N: 201337. Intended to assist the surgeon in providingJuly 26, 2017
- FDAPenumbra 3D Revascularization Device It is indicated for used in the revascularization of patients with acuteJuly 26, 2017
- FDA7245C, 7245C/E, 7245D Computer Digital Video System Product Usage: The 7245C, 7245C/E and 7245D are used toJuly 26, 2017
- FDAStandex International Bakers Pride Microwave Ovens Model E300July 26, 2017
- FDA9400 Laryngeal Strobe Product Usage: The 9310HD is used to electronically record, display, transfer, and storeJuly 26, 2017
Questions about this recall
Was PROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number PL-31790-02. Manufactured by: Flowonix Medical Inc., --- The correction involves the labeling of the device plus the following Prometra II pump labeling is also being revised: Intrathecal Catheter IFU, REF 11823, PL-22790-02; Catheter Revision Kit IFU, REF 11 830, PL-21798-02; Refill Kit IFU, REF 11825, PL-21794-00; Prometra II Patient Implant Card (Permanent) PL-32300-01; Prometra II Patient Implant Card (Temporary): PL-32375-01; Prometra II Patient Guide: PL-31912-01. The Prometra Programmable Infusion Pump System is indicated for intrathecal infusion of Infumorph (preservative-free morphine sulfate sterile solution) or preservative-free sterile 0.9% saline solution (sodium chloride injection, USP). recalled?
Yes. FDA published recall Z-2740-2017 on July 26, 2017. Reported hazard: Flowonix Medical received a report of a patient implanted with the Prometra II Programmable Pump who may have received a fatal drug overdose during an MRI procedure. The Prometra II pump has an FDA-approved design feature intended to permit safe exposure to an MRI without removing drug from the reservoir.
What should I do if I have this product?
Voluntary: Firm initiated · Letter